Home

Boston Scientific (BSX)

104.50
-0.01 (-0.01%)
NYSE · Last Trade: May 30th, 1:14 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close104.51
Open104.50
Bid103.57
Ask105.34
Day's Range103.87 - 105.00
52 Week Range71.88 - 107.17
Volume7,129,644
Market Cap148.79B
PE Ratio (TTM)76.28
EPS (TTM)1.4
Dividend & YieldN/A (N/A)
1 Month Average Volume6,532,399

Chart

About Boston Scientific (BSX)

Boston Scientific is a global medical technology company that specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. The company focuses on providing innovative therapies for various medical conditions, including those affecting the cardiovascular, urology, and gastrointestinal systems, among others. Boston Scientific is committed to advancing patient care through its pioneering technologies, which are designed to improve outcomes and enhance the quality of life for patients around the world. Their product offerings include devices for minimally invasive procedures, enabling healthcare professionals to deliver high-quality care efficiently and effectively. Read More

News & Press Releases

Michael Mahoney Turned Boston Scientific Into A Medical Tech Empireinvestors.com
Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.
Via Investor's Business Daily · May 29, 2025
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlookbenzinga.com
Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales.
Via Benzinga · May 28, 2025
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightensstocktwits.com
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
Via Stocktwits · May 28, 2025
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbottinvestors.com
The company said the regulatory path forward for one of its key systems is too murky to pursue.
Via Investor's Business Daily · May 28, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Growth Stock with Technical Breakout Potentialchartmill.com
Boston Scientific Corp (NYSE:BSX) shows strong growth fundamentals and a bullish technical setup, making it a compelling candidate for growth investors.
Via Chartmill · May 26, 2025
Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & Supplies - Diversified Pack
Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.
Via StockStory · May 25, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · May 20, 2025
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · May 20, 2025
What's going on in today's pre-market session: S&P500 moverschartmill.com
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.
Via Chartmill · May 20, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Growth Candidate Meeting Minervini’s Criteriachartmill.com
BOSTON SCIENTIFIC CORP (NYSE:BSX) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors.
Via Chartmill · May 19, 2025
Forecasting The Future: 9 Analyst Projections For Boston Scientificbenzinga.com
Via Benzinga · May 16, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Technical Setup in a Leading Medical Device Stockchartmill.com
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock has outperformed peers and exhibits bullish patterns with clear support and resistance levels.
Via Chartmill · May 13, 2025
3 Large-Cap Stocks with Solid Fundamentals
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Via StockStory · May 13, 2025
Is BOSTON SCIENTIFIC CORP (NYSE:BSX) suited for high growth investing?chartmill.com
A fundamental and technical analysis of (NYSE:BSX): Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing?
Via Chartmill · May 9, 2025
2 S&P 500 Stocks Worth Investigating and 1 to Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · May 5, 2025
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · May 1, 2025
3 Stocks Lifting 2025 Guidance Despite Market Jitters
See these three stocks that beat on earnings in Q1 and raised their guidance for the rest of 2025. These stocks are signaling strength amid tough conditions.
Via MarketBeat · April 29, 2025
2 Profitable Stocks Worth Your Attention and 1 to Keep Off Your Radar
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · April 29, 2025
GE HealthCare (GEHC) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow before market hours. Here’s what to expect.
Via StockStory · April 29, 2025
Align Technology Earnings: What To Look For From ALGN
Dental technology company Align Technology (NASDAQ:ALGN) will be reporting results tomorrow after market close. Here’s what you need to know.
Via StockStory · April 29, 2025
What To Expect From CONMED’s (CNMD) Q1 Earnings
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings tomorrow after market close. Here’s what you need to know.
Via StockStory · April 29, 2025
Is BOSTON SCIENTIFIC CORP (NYSE:BSX) following the Minervini trend for explosive growth?chartmill.com
A fundamental and technical analysis of (NYSE:BSX): Delving into BOSTON SCIENTIFIC CORP (NYSE:BSX)'s high Growth Prospects.
Via Chartmill · April 28, 2025
BSX Q1 Earnings Call: Outperformance Driven by Cardiology and Electrophysiology, Guidance Raised Amid Tariff Headwinds
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. The company expects next quarter’s revenue to be around $4.88 billion, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 11.5% above analysts’ consensus estimates. 
Via StockStory · April 24, 2025
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Resultsbenzinga.com
Via Benzinga · April 24, 2025
Why Boston Scientific (BSX) Stock Is Up Today
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS expectations. Organic sales growth topped the company's own forecast and was led by a 25.6% surge in its Cardiovascular segment, a signal that demand in its largest business is accelerating. Looking ahead, its revenue guidance for next quarter exceeded Wall Street's estimates. Overall, we think this was a decent quarter with some key metrics above expectations.
Via StockStory · April 23, 2025